Rayleen V Bowman
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Rayleen V Bowman has a total of 25 co-authors. Here are the top co-authors by number of shared publications:
- Ian Anthony Yang
The University of Queensland Thoracic Research Centre, The Prince Charles Hospital, Brisbane, Australia
5 shared publications - Kwun Meng Fong
Department of Thoracic Medicine, The Prince Charles Hospital, University of Queensland Thoracic Research Centre, Brisbane, Australia
5 shared publications - Belinda E. Clarke
The Prince Charles Hospital
2 shared publications - Casey Maree Wright
The University of Queensland Diamantina Institute, University of Queensland , Brisbane, Queensland 4102
2 shared publications - Edwina E. Duhig
Department of Anatomical Pathology, The Prince Charles Hospital, Brisbane, QLD 4032, Australia
2 shared publications - Linda Passmore
UQ Thoracic Research Centre, School of Medicine, The University of Queensland, Queensland, Australia
2 shared publications
Latest Publications
- Open Access
- 1 January 2014
- Published by Springer Nature in BMC Genomics
- Vol. 15 (1) , 88
MicroRNA-34c is associated with emphysema severity and modulates SERPINE1 expression
MicroRNAs (MiRNA) are small non-coding RNAs that regulate gene expression. The aim of this study was to identify miRNAs differentially expressed between mild and moderately emphysematous lung, as well as their functional target mRNAs. Resected lung from patients with COPD undergoing lung cancer surgery was profiled using miRNA (Agilent Human miRNA profiler G4470 V1.01) and mRNA (OperonV2.0) microarrays. Cells of lung origin (BEAS-2B and HFL1) were profiled using mRNA microarrays (Illumina HumanHT-12 V3) after in vitro manipulation.
- 1 January 2014
- Published by Springer Nature in BMC Genomics
- Vol. 15 (1) , 88
Open AccessMicroRNA-34c is associated with emphysema severity and modulates SERPINE1 expression
MicroRNAs (MiRNA) are small non-coding RNAs that regulate gene expression. The aim of this study was to identify miRNAs differentially expressed between mild and moderately emphysematous lung, as well as their functional target mRNAs. Resected lung from patients with COPD undergoing lung cancer surgery was profiled using miRNA (Agilent Human miRNA profiler G4470 V1.01) and mRNA (OperonV2.0) microarrays. Cells of lung origin (BEAS-2B and HFL1) were profiled using mRNA microarrays (Illumina HumanHT-12 V3) after in vitro manipulation.
- Open Access
- 25 September 2012
- Published by Springer Nature in BMC Cancer
- Vol. 12 (1) , 428
Pleural fluid cell-free DNA integrity index to identify cytologically negative malignant pleural effusions including mesotheliomas
The diagnosis of malignant pleural effusions (MPE) is often clinically challenging, especially if the cytology is negative for malignancy. DNA integrity index has been reported to be a marker of malignancy. The aim of this study was to evaluate the utility of pleural fluid DNA integrity index in the diagnosis of MPE.
- 25 September 2012
- Published by Springer Nature in BMC Cancer
- Vol. 12 (1) , 428
Open AccessPleural fluid cell-free DNA integrity index to identify cytologically negative malignant pleural effusions including mesotheliomas
The diagnosis of malignant pleural effusions (MPE) is often clinically challenging, especially if the cytology is negative for malignancy. DNA integrity index has been reported to be a marker of malignancy. The aim of this study was to evaluate the utility of pleural fluid DNA integrity index in the diagnosis of MPE.
- Open Access
- 13 June 2012
- Published by Springer Nature in BMC Pulmonary Medicine
- Vol. 12 (1) , 25
Genetic influences on right ventricular systolic pressure (RVSP) in chronic obstructive pulmonary disease (COPD)
Pulmonary hypertension (PH) is a complication of chronic obstructive pulmonary disease (COPD). This study examined genetic variations in mediators of vascular remodelling and their association with PH in patients with COPD. In patients with COPD, we genotyped 7 SNPs in 6 candidate PH genes (NOS3, ACE, EDN1, PTGIS, SLC6A4, VEGFA). We tested for association with right ventricular systolic pressure (RVSP), spirometry and gas transfer, and hypoxemia.
- 13 June 2012
- Published by Springer Nature in BMC Pulmonary Medicine
- Vol. 12 (1) , 25
Open AccessGenetic influences on right ventricular systolic pressure (RVSP) in chronic obstructive pulmonary disease (COPD)
Pulmonary hypertension (PH) is a complication of chronic obstructive pulmonary disease (COPD). This study examined genetic variations in mediators of vascular remodelling and their association with PH in patients with COPD. In patients with COPD, we genotyped 7 SNPs in 6 candidate PH genes (NOS3, ACE, EDN1, PTGIS, SLC6A4, VEGFA). We tested for association with right ventricular systolic pressure (RVSP), spirometry and gas transfer, and hypoxemia.
- Open Access
- 2 September 2009
- Published by Springer Nature in Respiratory Research
- Vol. 10 (1) , 81
Expression profiling identifies genes involved in emphysema severity
Chronic obstructive pulmonary disease (COPD) is a major public health problem. The aim of this study was to identify genes involved in emphysema severity in COPD patients.
- 2 September 2009
- Published by Springer Nature in Respiratory Research
- Vol. 10 (1) , 81
Open AccessExpression profiling identifies genes involved in emphysema severity
Chronic obstructive pulmonary disease (COPD) is a major public health problem. The aim of this study was to identify genes involved in emphysema severity in COPD patients.
- 2 May 2009
- Published by Taylor & Francis in Expert Opinion on Therapeutic Targets
- Vol. 13 (6) , 625-640
Epigenomic targets for the treatment of respiratory disease
A number of processes lead to epigenetic and epigenomic modifications. To address the importance of epigenomics in respiratory disease. Studies of epigenomics were analysed in relation to chronic respiratory diseases. In lung cancer and mesothelioma, a number of genes involved in carcinogenesis have been demonstrated to be hypermethylated, implicating epigenomic changes in the aetiology of these cancers. Hypermethylated genes have also been associated with lung cancer recurrence, indicating epigenomic regulation of metastasis. In airway diseases, modulation of histone function may activate inflammatory mechanisms in chronic obstructive pulmonary disease patients and lead to relative steroid resistance. There is emerging evidence for the role of epigenetic changes in chronic lung diseases such as asthma, including responses to environmental exposures in utero and to the effects of air pollution. Insight into epigenomics will lead to the development of novel biomarkers and treatment targets in respiratory diseases.
- 2 May 2009
- Published by Taylor & Francis in Expert Opinion on Therapeutic Targets
- Vol. 13 (6) , 625-640
Epigenomic targets for the treatment of respiratory disease
A number of processes lead to epigenetic and epigenomic modifications. To address the importance of epigenomics in respiratory disease. Studies of epigenomics were analysed in relation to chronic respiratory diseases. In lung cancer and mesothelioma, a number of genes involved in carcinogenesis have been demonstrated to be hypermethylated, implicating epigenomic changes in the aetiology of these cancers. Hypermethylated genes have also been associated with lung cancer recurrence, indicating epigenomic regulation of metastasis. In airway diseases, modulation of histone function may activate inflammatory mechanisms in chronic obstructive pulmonary disease patients and lead to relative steroid resistance. There is emerging evidence for the role of epigenetic changes in chronic lung diseases such as asthma, including responses to environmental exposures in utero and to the effects of air pollution. Insight into epigenomics will lead to the development of novel biomarkers and treatment targets in respiratory diseases.